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Background: Even though chronic fatigue syndrome and idiopathic chronic fatigue are quite common, there are
no clearly known causes. Most treatments are therefore symptomatic in nature, and chronic fatigue syndrome and
idiopathic chronic fatigue patients are highly interested in using oriental medicine or complementary and
alternative medicine treatment. Acupuncture, one of the major treatments used in oriental medicine, is effective in
treating various diseases. This study will attempt to analyze the effectiveness and safety of acupuncture in the
treatment of chronic fatigue by comparing the two treatment groups (body acupuncture, Sa-am acupuncture) and
the control group (usual care).
Methods/design: This study consists of a four-center, three-arm, randomized, controlled, and open-label trial. One
hundred and fifty participants are randomly divided into treatment groups A and B and a control group. The
treatment groups will receive acupuncture treatments either two or three times per week for a total of 10 sessions
over a period of 4 weeks. The control group will not receive acupuncture treatments and will continue their usual
care during this period. The primary outcome variable is the Fatigue Severity Scale, which will be utilized 5 weeks
after randomization. Secondary outcome variables are the Fatigue Severity Scale at 13 weeks, a short form of the
Stress Response Inventory, the Beck Depression Inventory, the Numeric Rating Scale, and the EuroQol-5 Dimension
at 5 and 13 weeks after randomization.
Discussion: This study will provide evidence with high external validity on the effectiveness and safety of
acupuncture as a treatment for chronic fatigue syndrome and idiopathic chronic fatigue.
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Fatigue is a subjective feeling of emptiness or a lack of
power that can affect one’s daily life during or after work [1].
Fatigue can be classified according to the duration of
symptoms. Fatigue is defined as transient fatigue when
symptoms disappear within 1 month, continuous fatigue
when symptoms last for longer than 1 month but less
than 6 months, and chronic fatigue when symptoms last
longer than 6 months [2]. Either a physical or a mental
cause of chronic fatigue is medically describable for
about two-thirds of patients. Medically indescribable
cases of chronic fatigue can be classified into chronic fa-
tigue syndrome (CFS) and idiopathic chronic fatigue
(ICF) [3]. CFS is prevalent in 1% of the total population
and ICF is prevalent in 10% [4]. The symptoms associ-
ated with a diagnosis of CFS include unexplained fatigue,
lasting longer than 6 months, new or definite onset, fa-
tigue that does not result from ongoing exertion and is
not substantially alleviated by rest, and a substantial re-
duction in previous levels of occupational, educational,
social, or personal activities. In addition to these symp-
toms, more than four of the following symptoms should
be concurrently present over 6 months: impaired mem-
ory or concentration, sore throat, tender cervical or axil-
lary lymph nodes, muscle pain, multi-joint pain, onset of
new headaches, unrefreshing sleep, and post-exertion
malaise. If a patient does not meet all the criteria for
CFS described above, he/she is diagnosed with ICF [5].
Since there is no recognized treatment because the
cause is not known, CFS and ICF patients are highly
interested in treatment using oriental medicine or com-
plementary and alternative medicine, and various ap-
proaches have been used [6].
Acupuncture is one of the most widely used oriental
medicine treatments. The previous systematic reviews
reported that many of the studies included in the re-
views showed that acupuncture and moxibustion treat-
ment were effective in treating chronic fatigue, but it is
difficult to judge the level of evidence due to methodo-
logical flaws of the studies [7-11].
Aside from the aforementioned systematic reviews,
three recently conducted randomized controlled trials
used a non-meridian point group as a control group. In
two of these trials, the treatment group showed a
marked improvement compared with the control group
[12,13], but no significant difference was observed in
one study [14]. There has been no proven placebo for
acupuncture. The non-meridian point groups in the
aforementioned studies are clearly considered not to be
physiologically inert. These studies may therefore have
had limitations in separating the specific effects of acu-
puncture [15].
This study was planned so as to use two forms of acu-
puncture; the first form, body acupuncture, indicatesacupuncture that is applied to the whole body, in com-
parison with microsystem acupuncture that is applied to
the specific local areas such as scalp acupuncture and
auricular acupuncture. Acupuncture has a history that is
at least 2,000 years old and has been used widely in
China, Korea, and Japan [16-18]; the second form,
Sa-am acupuncture, is traditional Korean acupuncture,
which was developed in the latter part of the Joseon
Dynasty. Sa-am acupuncture is a school of acupuncture
initiated by Sa-am, which is characterized by applying
the five-phase theory and the mother–child reinforce-
ment–reduction principle to the selection of points and
needling manipulation [12,16]. The control group is the
usual care group, and we will measure the overall effects
of acupuncture.
The aim of this study is to provide grounds for the ef-
fectiveness and safety of acupuncture by comparing the
two acupuncture treatment groups and the control group.
Methods/design
Design
A multicenter (four centers), randomized, controlled
trial will be conducted at the Department of Oriental
Rehabilitation Medicine at Gwangju Oriental Hospital of
Dongshin University, the Department of Acupuncture
and Moxibustion at Gangdong Oriental Hospital of
Kyung Hee University, the Department of Oriental
Gynecology at Jecheon Oriental Hospital of Semyung
University, and the Acupuncture, Moxibustion, and
Meridian Research Group of the Korea Institute of
Oriental Medicine.
Participants who are considered suitable for the study
will receive a total of 10 acupuncture treatments or
usual care after they are randomly appointed to treat-
ment group A (body acupuncture group), treatment
group B (Sa-am acupuncture group), or the control
group (usual care group). The treatment groups will re-
ceive the acupuncture treatments for 4 weeks, two to
three times a week. This allows for a flexible treatment
regime of once a week or four times a week up to each
once. The total study period will be 13 weeks: a screen-
ing period of 1 week, a treatment period of 4 weeks, and
a follow-up period of 8 weeks. The study flow is
depicted in Figure 1.
Randomization and allocation concealment
A total of 150 participants will be randomly allocated
into treatment group A, treatment group B, or the con-
trol group. Dongshin, Kyung Hee, and Semyung Univer-
sity Hospitals will each recruit 45 patients, and the
Korea Institute of Oriental Medicine will recruit 15 pa-
tients. To select the three groups, this study will use
block stratified randomization that has four institutions




Treatment Group A (N=50)
Body Acupuncture
10 times for 4 weeks
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Screening by Inclusion and Exclusion 
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Figure 1 Study flow chart.
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ware, version 9.1.3; SAS Institute Inc., Cary, NC, USA).
Randomly allocated envelopes will be sealed in opaque
envelopes and delivered to each center and stored in
double-locked cabinets. Random allocation will be
performed at the second visit for participants who
consented in written form and satisfied all selection
standards. Before the implementation of random alloca-
tion, a clinical research coordinator at each clinical
center will record the details of the newly included par-
ticipant (name, date of birth, participant and center
codes, date of inclusion) in case report forms and pre-
pare a copy of the signed informed consent form. The
researcher will open random allocation envelopes in
order in front of participants and allocate them to each
group. The random allocation envelops will be opened
after participants complete baseline assessments. The
practitioners and participants will get to know the allo-
cated group according to the research design but the
outcome assessors and data analysts will not know. The
clinical research coordinator will provide participant
identification codes and record them in case report
form. The opened envelopes will be stored separately in
double-locked cabinets.
Blinding
This is an unblinded study.
Ethics
Written consent will be obtained from each participant.
This study’s protocol was approved by all relevant insti-
tutional review boards: Gwangju Oriental Hospital of
Dongshin University, Gangdong Oriental Hospital of
Kyung Hee University, Jecheon Oriental Hospital of
Semyung University, and Daejeon Oriental Hospital of
Daejeon University.Participants
This study will use the following the inclusion criteria:
(1) males and females aged 19 to 65; (2) the presence of
unexplained fatigue that is continuous and repetitive for
more than 6 months; (3) the absence of abnormal find-
ings in all of the following: blood pressure, complete
blood count (hemoglobin, hematocrit, white blood cell,
glucose), biochemical examination (aspartate amino-
transferase, alanine aminotransferase, creatinine), elec-
trolyte (sodium, potassium, chloride), thyroid function
test (thyroid stimulating hormone, free thyroxine), preg-
nancy test (fertile woman), chest X-ray, and electrocar-
diogram; and abnormality criteria as follows: (a) diastolic
blood pressure ≥90 mmHg (after putting the subjects at
rest for more than 5 minutes, diastolic blood pressure is
measured twice at an interval of 2 minutes or longer
while the subjects are seated and the results are aver-
aged); (b) hemoglobin <13 g/dl and hematocrit <38% for
male adults, hemoglobin <11.5 g/dl and hematocrit
<36% for female adults, white blood cell ≥11,000/mm3,
random plasma glucose ≥200 mg/dl; (c) aspartate amino-
transferase ≥50 IU/l and alanine aminotransferase ≥50
IU/l, creatinine ≥1.5 mg/dl; (d) sodium <135 mmol/l or
≥145 mmol/l, potassium <3.5 mmol/l or ≥5.5 mmol/l,
chloride <97 mmol/l or ≥110 mmol/l; (e) thyroid stimu-
lating hormone <0.35 mIU/ml or ≥5.50 mIU/ml, free
thyroxine <0.89 ng/dl or ≥1.76 ng/dl; (f ) urine human
chorionic gonadotropin is (+); (g) lesions of pulmonary
tuberculosis, other than inactive tuberculosis on a chest
X-ray; (h) arrhythmia requiring treatment, ischemic
heart disease, or cardiomegaly indicated from an electro-
cardiogram; (4) a Numeric Rating Scale [19] score ≥4 for
the week prior to the screening visit; and (5) those who
consent to participate in this trial and sign an informed
consent statement after listening to a clear explanation
of the purpose and characteristics of this clinical trial.
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the presence of the following conditions in the subject’s
past history that might trigger chronic fatigue: (a) or-
ganic causes, such as acute or chronic liver disease (for
example, hepatitis, liver cirrhosis), anemia, tuberculosis,
chronic lung disease, cardiovascular disease (for ex-
ample, heart failure, hypertension), endocrine/metabolic
disease (for example, diabetes, thyroid gland disease,
severe obesity), autoimmune disease (for example,
rheumatoid arthritis, systemic lupus erythematosus,
multiple sclerosis), malignant tumors, or infectious dis-
ease; and (b) psycho-social causes, such as depression,
anxiety neurosis, recent severe stress, schizophrenia,
alcoholism, or an eating disorder (anorexia nervosa,
bulimia nervosa); (2) subjects who have taken the follow-
ing drugs within the past 2 weeks: antihypertensive
drugs, antidepressants, anti-anxiety agents, hypnotics, or
antihistamines; (3) pregnant or breast-feeding women;
(4) subjects who are participating in other clinical trials;
(5) subjects who are overworked; (6) subjects who have
experienced a hypersensitive reaction after acupuncture
treatment (in the case of participants with an experience
of acupuncture treatment); (7) subjects who are inmates
at group facilities, such as social welfare institutions; (8)
subjects who do not provide informed consent; and (9)
others whose clinical trial conductors are considered in-
appropriate for participating in this trial [5,20].
We will recruit participants using advertisements in
local newspapers, the websites of local universities, and
posters displayed in hospitals. Respondents will go
through telephone pre-screening led by the clinical trial
coordinator to ensure they meet the inclusion criteria
(1), (2), and (4). The next step will be for participants to
visit their local clinical trial center and go through a
more in-depth screening process to determine whether
they satisfy the inclusion criteria or meet the exclusion
criteria.
Intervention
Treatment groups will receive acupuncture treatment a
total of 10 times for 4 weeks, and the control group will
continue receiving their usual care. Meridian points that
were used in two pilot studies will be applied to the two
treatment groups [12,18]. The practitioner who will be
providing treatment is a doctor of Korean medicine with
over 3 years of practical experience and will have one
training session so that he/she will be able to treat ac-
cordingly. Disposable needles with a diameter of 0.25
mm and a length of 30 mm (Dongbang Acupuncture
Incorporation, Gyeonggi-do, Korea) will be used.
Treatment group A (body acupuncture group)
The participants randomly assigned to treatment group
A will be treated while they are in a prone position. Atone acupuncture point on the head (GV20), the needle
will be leaned anterior to the body and inserted 0.5 to
1.5 F-cun, unilaterally. At one acupuncture point on the
neck (GB20), the needle will be inserted 0.3 to 1.0 F-cun
in the direction of the opposite eye bilaterally. At six
points in the back region (BL11, BL13, BL15, BL18,
BL20, BL23), the needle will be leaned 45 to 90° towards
the bottom and inserted 0.5 to 1.0 F-cun, bilaterally. The
needles will be retained for 15 minutes without using
the twirling method [18].
Treatment group B (Sa-am acupuncture group)
The participants appointed to treatment group B will be
treated while they sit in a chair. Males will be treated on
the left side and females will be treated on the right side.
The acupoints used for this treatment will all be uni-
lateral. At LU8 in the wrist region, the needle will be
leaned 45° downward and inserted 0.5 to 0.7 F-cun. At
SP3 in the foot region, the needle will be leaned 45° up-
ward and inserted 0.3 to 0.5 F-cun. At HT8 in the palm
region, the needle will be leaned 45° downward and
inserted 0.3 to 0.5 F-cun. At BL15 in the back region,
the needle will be leaned 45 to 90° upward and inserted
0.5 to 1.0 F-cun. Finally, at CV6 in the abdominal region,
the needle will be leaned 45° downward and inserted 0.5
to 1.0 F-cun.
The needles will be retained for 15 minutes. The
needles will be twirled nine times for LU8, SP3, and
HT8, and twirled six times for BL15 and CV6 [12,21].
Control group (usual care group)
Participants in the control group will not receive acu-
puncture treatment A (body acupuncture) or B (Sa-am
acupuncture) but will be able to receive the necessary in-
dividualized usual care except acupuncture treatment for
chronic fatigue.
Permitted and prohibited concomitant treatments
Participants in both treatment groups and the control
group will be allowed to use any other form of treatment,
including acupuncture, moxibustion, herbal medicine, phys-
ical treatment, conventional medication, over-the-counter
drugs, supplements, and exercise, with the exception of
acupuncture treatment for chronic fatigue. Educational
materials explaining chronic fatigue will be given to parti-
cipants in all three of the groups.
Collection of baseline information
This study will collect information on the participants’
sex, age, height, weight, body mass index, education de-
gree, job, marital status, regular eating habits, frequency
of exercise, history of smoking, motivation for participat-
ing, and past health history related to chronic fatigue.
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Primary
The Fatigue Severity Scale (FSS) will be used as the pri-
mary outcome measurement. The FSS uses a series of nine
questions to evaluate the participants’ level of fatigue over
the previous week applying a rating scale between 1 and 7.
The final FSS score represents the average level of fatigue,
and higher scores mean more fatigue [22].
Secondary
A short form of the Stress Response Inventory evaluates
the participants’ stress reactions using the revised Stress
Response Inventory, which uses a total of 22 questions
covering the following three categories: somatization
(nine items), depression (eight items), and anger (five
items). For each of the questions, participants are asked
to indicate the degree to which they have experienced
stress over the prior week. The analysis is conducted by
adding the scores within each category and then deter-
mining the total score [23].
The Beck Depression Inventory consists of 21 ques-
tions, including recognition, emotional, motivational,
and physical symptoms of depression. Each category has
four items that describe the participants’ level of depres-
sion. Scores range from 0 to 3 for each choice (items 1
to 4), and the scores are summed for analysis [24].
The Numeric Rating Scale uses a horizontal line scaled







Laboratory test, chest X-ray, electrocardiogram, pregnancy test ●
Inclusion/exclusion criteria ●
Numeric rating scale ●
Vital signs ●
Change of medical history
Random allocation
Treatment expectancy questionnaire
Chronic fatigue syndrome questionnaire
Fatigue Severity Scale ●
A short form of Stress Response Inventory ●




●, all groups; ○, treatment groups.level of fatigue (0 = ‘no fatigue’ and 10 = ‘most severe
level of fatigue one can imagine’) [18].
The EuroQol-5 Dimension evaluates health-related
quality of life and consists of the EuroQol-5 Dimension
descriptive system and the EuroQol-5 Dimension Visual
Analogue Scale. The EuroQol-5 Dimension descriptive
system consists of five dimensions, including mobility,
self-care, usual activities, pain/discomfort, and anxiety/
depression. Each of these is further evaluated into three
levels. The EuroQol-5 Dimension Visual Analogue Scale
indicates the participants’ health condition on a scale
ranging from 0 to 100 [25,26].
Other assessment measures
The treatment expectancy of each subject [27], as well
as whether or not the subject satisfies the diagnostic cri-
teria for CFS [2,5], will also be assessed.
The detailed outcome assessment time points are pro-
vided in Table 1.
Hypothesis and sample size
The following two hypotheses are related to the differences
between the treatment groups and the control group:
H0 : μ1 ¼ μ3; μ2 ¼ μ3
H1 : μ1≠μ3 or μ2≠μ3
where μ1 is the FSS mean score for treatment group A, 5Treatment Follow-up
2 3 4 5 6 7 8 9 10 11 12 13
1~4 5 13
○ ● ●
● ○ ○ ○ ○ ○ ○ ○ ○ ○ ● ●








○ ○ ○ ○ ○ ○ ○ ○ ○ ○
● ○ ○ ○ ○ ○ ○ ○ ○ ○ ● ●
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for treatment group B, 5 weeks after random allocation;
and μ3 is the FSS mean score for control group, 5 weeks
after random allocation.
Referring to the previous study [28], the researchers
expect that the difference between treatment group A
and the control group will be smaller than the difference
between treatment group B and the control group. This
study therefore calculated the sample size taking into
consideration the difference between treatment group A
and the control group while applying the Bonferroni
method, which is conservative among multiple compari-
son methods.
In the present study, changes from baseline in FSS
mean score in the control group were calculated under
the assumption that they would approximate 5% of
changes in FSS mean score for treatment group A. The
final calculated difference in changes in FSS mean score
between the two groups was 0.915 with a standard devi-
ation of 1.1479 [12,29].
Using the mean comparison method, this study will
use an α value of 5%, a power of 90%, and the two-sided
test:
n ¼ 2 Zα=4 þ Zβ
 2  σ2
δ2




When the same number of patients is allocated for
treatment groups A and B and the control group, each
group has 40 patients. Considering a 20% dropout rate,
each group will require 50 initial participants.
Statistical methods
The analysis set consists of a full analysis set and a per-
protocol set.
The full analysis set represents the set of subjects that
is as close as possible to the ideal implied by the
intention-to-treat principle.
The per-protocol set is the set of data generated by the
subset of subjects who comply with the protocol suffi-
ciently enough to ensure that these data will be likely to
exhibit the effects of treatment, according to the under-
lying scientific model. Compliance covers such consider-
ations as exposure to acupuncture treatment eight or
more times, the availability of measurements, and the
absence of major protocol violations [30].
Both sets will be analyzed and the full analysis set will
be considered to be the primary analysis.
Of the sociodemographic characteristics and treatment
expectancy, continuous data will provide the mean and
standard deviation while the categorical data will provide
the frequency and percentage.For the treatment expectancy questionnaire, this study
will use analysis of variance. When there is a significant
between-group difference, we will add treatment expect-
ancy as a covariate and use analysis of covariance for a
primary outcome variable and compare it with the ana-
lysis results that do not use treatment expectancy as a
covariate.
The CFS questionnaire will provide the frequencies
and percentages of participants who adequately meet the
CFS diagnosis criteria.
For the group comparisons of these variables, this
study will use one-way analysis of variance when the
continuous data satisfy a normal distribution or will use
the Kruskal–Wallis test when these data do not follow a
normal distribution. For categorical data, a chi-squared
test will be used.
The primary and secondary outcomes 5 and 13 weeks
after random allocation are the dependent variables; the
baseline observed value is the covariate, and the allo-
cated group and the institutions are factors; this study
will use analysis of covariance. Testing of the hypotheses
will be done using an α value of 5% and a power of 90%.
When analysis of covariance acquires significant results,
then a multiple comparison will be conducted to see
which groups show differences.
Missing data will be processed with mixed model for
repeated measurements method.
Data and safety monitoring
Regular monitoring will be conducted for quality control.
Monitoring confirms whether the practical research-
related data are correct compared with the source docu-
ment as well as whether the research follows the approved
protocol.
Adverse events indicate undesirable and unintentional
signs, symptoms, or diseases that appear after the practical
experiment, and they do not have to be causally related to
the treatment. Safety will be evaluated based on the fre-
quency, severity, and symptoms of the adverse event.
Discussion
This study is designed as a pragmatic clinical trial to
more closely reflect the effects of everyday treatment of
acupuncture [31]. The results of this study are expected
to provide evidence, with high external validity, for the
effectiveness and safety of two common forms of acu-
puncture treatment on chronic fatigue patients.
In this study, the meridian points that will be used on
the participants in treatment group A are intended to re-
lieve the mind, clear the spirit, tranquilize the body to
free it from tension, and regulate the functions of in-
ternal organs [18].
Sa-am acupuncture treatment is largely divided into
three types: fixed pattern, transformed pattern and
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types were applied to the participants in the treatment
group B [12,32].
Trial status
The present study is currently recruiting participants.
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